MODULATION OF CA2+ INFLUX IN THE OVINE SOMATOTROPH BY GROWTH HORMONE-RELEASING FACTOR

被引:47
|
作者
CHEN, C
CLARKE, IJ
机构
关键词
CALCIUM ION; CURRENT; PITUITARY;
D O I
10.1152/ajpendo.1995.268.2.E204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Voltage-gated Ca2+ currents were recorded using the nystatin-perforated whole cell recording configuration on the ovine somatotrophs. With the use of Ca2+-tetraethylammonium chloride bath solution and Cs+ electrode solution, two types of Ca2+ currents were obtained with a predominant long-lasting (L) current blocked by nifedipine. A transient (T) current was isolated in the presence of nifedipine (3 mu M) and was not blocked by omega-conotoxin (5 mu M), but diminished to 47 +/- 5% of control by Ni2+- (0.3 mM) or to 52 +/- 10% of control by amiloride (0.5 mM). The nifedipine-blockable L-type current was not affected by omega-conotoxin (5 mu M); it was, however, attenuated to 80 +/- 4% of control by Ni2+ (0.3 mM) and to 48 +/- 6% of control by amiloride (0.5 mM). Cd2+ (1 mM) totally prevented both T and L currents. Application of growth hormone-releasing factor (GRF, 10 nM) reversibly increased the amplitude of both Ca2+ currents without modifying their kinetic properties. The effect-of GRF was observed similar to 30 s after application, peaked (142 +/- 11% of control, n = 5) rapidly, and lasted > 10 min if GRF treatment was continuous. Intracellular Ca2+ concentration ([Ca2+](i)) was increased by GRF (10 nM) within seconds, reaching a peak within 30 s and lasting > 250 s. Blockade of Ca2+ channels (Cd2+, 1 mM) or the use of Ca2+-free solution reduced basal [Ca2+](i) and significantly (P < 0.05) diminished the effect of GRF on [Ca2+](i). The secretion of growth hormone (GH) was increased significantly (P < 0.05) by GRF (10 nM), but the response was totally prevented by the application of Cd2+ (1 mM) or nifedipine (3 mu M). These are the first data to show that GRF acts directly on voltage-gated Ca2+ channels to increase Ca2+ permeability of the ovine somatotroph cell membrane. The subsequent increase in [Ca2+](i) and resultant GH secretion in response to GRF appears to be attributable to this Ca2+ influx.
引用
收藏
页码:E204 / E212
页数:9
相关论文
共 50 条
  • [21] PRIMARY STRUCTURE OF OVINE HYPOTHALAMIC LUTEINIZING HORMONE-RELEASING FACTOR (LRF)
    BURGUS, R
    BUTCHER, M
    AMOSS, M
    BLACKWELL, R
    VALE, W
    LING, N
    RIVIER, J
    MONAHAN, M
    FELLOWS, R
    GUILLEMIN, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (01) : 278 - +
  • [22] Differential desensitization response of the neonatal and adult rat somatotroph to growth hormone-releasing hormone and phorbol ester
    Collins, BJ
    Szabo, M
    Cuttler, L
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 117 (01) : 75 - 81
  • [23] GROWTH HORMONE-RELEASING HORMONE
    FROHMAN, LA
    JANSSON, JO
    ENDOCRINE REVIEWS, 1986, 7 (03) : 223 - 253
  • [24] Regulation by growth hormone-releasing hormone and somatostatin of a Na+ current in the primary cultured rat somatotroph
    Kato, M
    Sakuma, Y
    ENDOCRINOLOGY, 1997, 138 (12) : 5096 - 5100
  • [25] GROWTH HORMONE-RELEASING HORMONE AND GROWTH HORMONE-RELEASING PEPTIDE AS POTENTIAL THERAPEUTIC MODALITIES
    THORNER, MO
    VANCE, ML
    ROGOL, AD
    BLIZZARD, RM
    VELDHUIS, JD
    CAUTER, EV
    COPINSCHI, G
    BOWERS, CY
    ACTA PAEDIATRICA SCANDINAVICA, 1990, : 29 - 32
  • [26] Growth hormone-releasing factor affects macronutrient intake during the anabolic phase of zinc repletion: Total hypothalamic growth hormone-releasing factor content and growth hormone-releasing factor immunoneutralization during zinc repletion
    Rains, TM
    Mangian, HF
    Liang, T
    Cole, AC
    Beverly, JL
    Shay, NF
    NUTRITIONAL NEUROSCIENCE, 2001, 4 (04) : 283 - 293
  • [27] SOMATOTROPH HYPERPLASIA - SUCCESSFUL TREATMENT OF ACROMEGALY BY REMOVAL OF A PANCREATIC-ISLET TUMOR SECRETING A GROWTH HORMONE-RELEASING FACTOR
    THORNER, MO
    PERRYMAN, RL
    CRONIN, MJ
    ROGOL, AD
    DRAZNIN, M
    JOHANSON, A
    VALE, W
    HORVATH, E
    KOVACS, K
    JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05): : 965 - 977
  • [28] ANTIBODIES TO GROWTH HORMONE-RELEASING FACTOR INHIBIT SOMATIC GROWTH
    WEHRENBERG, WB
    BLOCH, B
    PHILLIPS, BJ
    ENDOCRINOLOGY, 1984, 115 (03) : 1218 - 1220
  • [29] Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans
    Gianotti, L
    Maccario, M
    Lanfranco, F
    Ramunni, J
    Di Vito, L
    Grottoli, S
    Muller, EE
    Ghigo, E
    Arvat, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10): : 3604 - 3608
  • [30] Capacitative Ca2+ influx and a diffusible influx factor
    Hallett, MB
    Pettit, EJ
    Davies, EV
    BIOCHEMICAL JOURNAL, 1996, 314 : 1054 - 1055